NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ:ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Acadia and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ:SVRA) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 25-cv-05147, is

The globalPatient Experience Technology Market, valued at US$0.59 billion in 2024, stood at US$0.66 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. Growing emphasis on value-based care, regulatory mandates for patient

Trusted heritage brand introduces a new line designed to nourish, protect, and perfect the booming boho braid trend Jamaican Mango & Lime®, the most trusted name in loc and braid maintenance and styling, proudly announces the launch of its Boho Styles & Trends Collection, a complete care system created to support one of today's most

NEW YORK, NY, NY / ACCESS Newswire / October 17, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Stride, Inc. ("Stride" or the "Company") (NYSE:LRN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Stride and certain of its officers and/or directors

SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced the oral presentation of the first disclosure of the safety and efficacy data from the global phase I US-Lung-101 study (NCT05983432) ofiza-bren (BL-B01D1), a potentially first-in-class EGFR x HER3 bispecific antibody-drug conjugate (ADC), at the European Society for Medical Oncology

— Data from the Phase Ib Beamion LUNG-1 trial evaluating HERNEXEOS® (zongertinib tablets) in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC was presented for the first time at ESMO 2025. — Confirmed response by blinded independent central review was 77%, with 96% of patients achieving disease control.1 — HERNEXEOS recently received Breakthrough Therapy Designations for

Degree will prepare students to use engineering skills as a medium for artistic expression California Institute of the Arts (CalArts) proudly announces the launch of its bachelor of fine arts (BFA) program in Creative Computing, which will enroll its first students in the fall of 2026. This interdisciplinary program, among the first in the United

Integrity's transformative technology and platform of integrated resources empowers the Tristate Financial Network team to better anticipate and meet the increasingly diverse needs of agents and clients Integrity, LLC (“Integrity”), a leading distributor of life and health insurance, and provider of wealth management and retirement planning solutions, today announced it has partnered with Tristate Financial